Long-term outcome of steroid-resistant nephrotic syndrome in children

Agnes Trautmann, Sven Schnaidt, Beata S. Lipska-Ziȩtkiewicz, Monica Bodria, Fatih Ozaltin, Francesco Emma, Ali Anarat, Anette Melk, Marta Azocar, Jun Oh, Bassam Saeed, Alaleh Gheisari, Salim Caliskan, Jutta Gellermann, Lina Maria Serna Higuita, Augustina Jankauskiene, Dorota Drozdz, Sevgi Mir, Ayse Balat, Maria SzczepanskaDusan Paripovic, Alexandra Zurowska, Radovan Bogdanovic, Alev Yilmaz, Bruno Ranchin, Esra Baskin, Ozlem Erdogan, Giuseppe Remuzzi, Agnieszka Firszt-Adamczyk, Elzbieta Kuzma-Mroczkowska, Mieczyslaw Litwin, Luisa Murer, Marcin Tkaczyk, Helena Jardim, Anna Wasilewska, Nikoleta Printza, Kibriya Fidan, Eva Simkova, Halina Borzecka, Hagen Staude, Katharina Hees, Franz Schaefer

Research output: Contribution to journalArticle

Abstract

Weinvestigated the value of genetic, histopathologic, and early treatment response information inprognosing longterm renal outcome in children with primary steroid-resistant nephrotic syndrome. From the PodoNet Registry, we obtained longitudinal clinical information for 1354 patients (disease onset at>3months and<20 years of age): 612 haddocumentedresponsiveness tointensifiedimmunosuppression (IIS),1155hadkidneybiopsy results, and212had an established genetic diagnosis. We assessed risk factors for ESRD using multivariate Cox regression models. Complete and partial remission of proteinuria within 12 months of disease onset occurred in 24.5% and 16.5% of children, respectively, with the highest remission rates achievedwith calcineurin inhibitor-based protocols. Ten-year ESRD-free survival rates were 43%, 94%, and 72% in children with IIS resistance, complete remission, and partial remission, respectively; 27% in children with a genetic diagnosis; and 79% and 52% in children with histopathologic findings of minimal change glomerulopathy and FSGS, respectively. Five-year ESRD-free survival rate was 21% for diffuse mesangial sclerosis. IIS responsiveness, presence of a genetic diagnosis, and FSGS or diffuse mesangial sclerosis on initial biopsy as well as age, serum albumin concentration, and CKD stage at onset affected ESRD risk. Our findings suggest that responsiveness to initial IIS and detection of a hereditary podocytopathy are prognostic indicators of favorable and poor long-term outcome, respectively, in children with steroid-resistant nephrotic syndrome. Childrenwithmultidrug-resistant sporadic disease showbetter renal survival than thosewith geneticdisease. Furthermore, histopathologic findings may retain prognostic relevance when a genetic diagnosis is established.

Original languageEnglish
Pages (from-to)3055-3065
Number of pages11
JournalJournal of the American Society of Nephrology
Volume28
Issue number10
DOIs
Publication statusPublished - Oct 1 2017

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Long-term outcome of steroid-resistant nephrotic syndrome in children'. Together they form a unique fingerprint.

  • Cite this

    Trautmann, A., Schnaidt, S., Lipska-Ziȩtkiewicz, B. S., Bodria, M., Ozaltin, F., Emma, F., Anarat, A., Melk, A., Azocar, M., Oh, J., Saeed, B., Gheisari, A., Caliskan, S., Gellermann, J., Higuita, L. M. S., Jankauskiene, A., Drozdz, D., Mir, S., Balat, A., ... Schaefer, F. (2017). Long-term outcome of steroid-resistant nephrotic syndrome in children. Journal of the American Society of Nephrology, 28(10), 3055-3065. https://doi.org/10.1681/ASN.2016101121